Evidence map›Paper›PMID 39200540›Full record

ArticleFoods (Basel, Switzerland)2024

Industrial Production of Bioactive Nutrient-Enhanced Extra Virgin Olive Oil under Continuous-Flow Ultrasound and Pulsed Electric Field Treatment.

Luisa Boffa, Emanuela Calcio Gaudino, Giorgio Grillo, Arianna Binello, Giorgio Capaldi, Duarte Rego, Marcos Pereira, Giancarlo Cravotto

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luisa BoffaDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.ORCID 0000-0002-9124-3811
Emanuela Calcio GaudinoDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.ORCID 0000-0001-9602-0310
Giorgio GrilloDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.ORCID 0000-0002-3538-4185
Arianna BinelloDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.ORCID 0000-0002-4406-3041
Giorgio CapaldiDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.ORCID 0000-0001-7858-6628
Duarte RegoEnergyPulse Systems, Est Paco Lumiar Polo Tecnológico Lt3, 1600-546 Lisbon, Portugal.
Marcos PereiraEnergyPulse Systems, Est Paco Lumiar Polo Tecnológico Lt3, 1600-546 Lisbon, Portugal.
Giancarlo CravottoDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.ORCID 0000-0001-7574-7350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extra virgin olive oil (EVOO) is a cornerstone of the Mediterranean diet. Many studies have highlighted its crucial preventive role against cardiovascular disease, neurodegenerative disorders, metabolic syndrome and cancer, with these effects being due to the synergistic anti-inflammatory and antioxidant activities of minor components, such as polyphenols and tocols. The aim of the present study is to implement new technologies for olive oil mills and develop an efficient large-sized industrial process for the continuous extraction of healthier EVOOs that are enriched with these bioactive compounds. Non-thermal technologies, namely ultrasound (US) and pulsed electric field (PEF), have been tested, separately and in combination, to eliminate the need for traditional malaxation. There is extensive literature to support the efficacy of ultrasound-assisted extraction (UAE) and PEF treatments in EVOO production. A newly designed US device and a PEF industrial chamber have been combined into a single, integrated continuous-flow setup, the performance of which in the extraction of EVOO from green Coratina olives has been evaluated herein. Extraction yields, physico-chemical and organoleptic characteristics, and polyphenol and tocol contents were monitored throughout the trials, and the last three were measured at accelerated aging times (AAT) of 15 and 30 days. The US and combined US-PEF processes not only increased daily oil production (ton/day, by nearly 45%), but also eliminated the need for kneading during malaxation, resulting in significant energy savings (approximately 35%). In addition, these innovations enriched the resulting EVOO with nutritionally relevant minor components (8-12% polyphenols, 3-5% tocols), thereby elevating its quality and market value, as well as overall stability. The introduction of continuous-flow US and PEF technologies is a remarkable innovation for the EVOO industry, as they offer benefits to both producers and consumers. The EVOO resulting from non-thermal continuous-flow production meets the growing demand for healthier, nutrient-enriched products.

Indexed as

accelerated shelf-lifeextra virgin olive oil (EVOO)flow processgreen Coratinaindustrial scalepolyphenolspulsed electric fieldtocopherolsultrasound

Identifiers

PMID39200540
PMCPMC11353453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.